論文・学会発表|呼吸器内科

論文

令和6年度

著者名・科名・共同著者名 題名(雑誌・書籍名)
Shinnosuke Onaka
呼吸器内科
Rino Arai,(Mizuka Tanifuji, Asuka Nagai, Akinori Ebihara, Tokuzen Iwamoto), Mayumi Aoyama,( Makoto Otaki, Hidenobu Shigemitsu, Ichiro Kuwahira)
A case of endobronchial mucosa-associated lymphoid tissue (MALT) lymphoma successfully treated with radiotherapy and a review of the literature Respirol Case Rep. 2024 May 8;12(5):e01369.doi: 10.1002/rcr2.1369.
Ayako Shimada
呼吸器内科
(Xingyu Zhou, Chen Ye, Takayuki Okamoto, Yuma Iwao, Naoko Kawata, Hideaki Haneishi)
Multi-modal evaluation of respiratory diaphragm motion in chronic obstructive pulmonary disease using MRI series and CT images pn J Radiol. 2024 Dec;42(12):1425-1438.doi: 10.1007/s11604-024-01638-9. Epub 2024 Aug 3.
Ayako Shimada
呼吸器内科
Shinnosuke Ohnaka, Masanao Nakashima, Atsushi Nagai
Transcriptome Analysis of Fibroblasts in Hypoxia Induced Vascular Remodeling: Functional Roles of CD26/DPP4 Int J Mol Sci. 2024 Nov 23;25(23):12599.doi: 10.3390/ijms252312599.
Ayako Shimada
呼吸器内科
Yuri Suzuki, Takeshi Kawasaki, Koichiro Tatsumi, Tadasu Okaya, Shun Sato, Tomoko Misawa, Ryo Hatano, Chikao Morimoto, Yoshitoshi Kasuya, Yoshinori Hasegawa, Osamu Ohara, Takuji Suzuki
Successful Resection of Small Intestinal Stenosis After Treatment With an Immune Checkpoint Inhibitor for Metastatic Lung Cancer in the Small Intestine: A Case Report Cureus. 2024 Dec 17;16(12):e75909. doi:10.7759/cureus.75909.

令和5年度

著者名・科名・共同著者名 題名(雑誌・書籍名)
永井厚志
呼吸器内科
環境保健サーベイランス・局 地的大気汚染健康影響検討会 (有識者会議) 令和3年度大気汚染に係る環 境保健サーベイランス報告書. 令和5年11月、環境省環境 保健部

令和4年度

著者名・科名・共同著者名 題名(雑誌・書籍名)
Masanao Nakashima
呼吸器内科
Shimada A, Ohnaka S, Kubo K, Nagai A
COVID-19-Associated Pulmonary Aspergillosis in a Patient Treated With Remdesivir, Dexamethasone, and Baricitinib: A Case Report. Cureus. 2022 Apr 2;14(4): e23755. doi: 10.7759/cureus.23755. eCollection 2022 Apr.
Masanao Nakashima
呼吸器内科
Abe T, Yoshida N, Shimada T, Nagai A
Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases. PLoS One. 2022 Nov 17;17(11): e0276859.
Masanao Nakashima
呼吸器内科
Tanaka H, Tanzawa S, Misumi T, Makiguchi T, Inaba M, Honda T, Nakamura J, Inoue K, Kishikawa T, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Fukuda Y, Yasugi M, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Shiraishi K, Matsutani N, Seki N.
Ther Adv Med Oncol. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study): primary analysis. Ther Adv Med Oncol. 2022 Dec 18;14:17588359221142786.
Masanao Nakashima
呼吸器内科
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N.
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study). Ther Adv Med Oncol. 2022 Jul 29;14:17588359221116603.